Laurie Stelzer

Laurie serves as a board member to Sionna and is acting Chief Financial Officer of SKIA Holdings. She currently serves on the Board of MBX Biosciences, Spyre Therapeutics, and is Chair of the Board of PMV Pharmaceuticals, Inc. Laurie has over 25 years of finance and business development leadership experience in the biopharmaceutical industry. She has held leadership roles in finance, treasury, global accounting, business development, project management, and site operations for a range of biopharmaceutical companies including as Chief Financial Officer of Kailera Therapeutics, Orna Therapeutics, Mirati Therapeutics, Inc., Arena Pharmaceuticals, Inc., and Halozyme Therapeutics, Inc. She also held senior management roles at Shire Plc and Amgen, Inc., and previously served on the board of Surface Oncology, Inc. and Longboard Pharmaceuticals. Laurie earned a B.S. in Accounting from Arizona State University and an M.B.A. from University of California, Los Angeles, Anderson School of Management.